Nano3A: A New Cell Systems Nanotechnology Approach To Drug Discovery | 14054
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google Scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Nano3A: A new cell systems nanotechnology approach to drug discovery

2nd World Congress on Biotechnology

J Lodewyk F Kock

Key Note Forum: J Microbial Biochem Technol

DOI: 10.4172/1948-5948.S1.01

This Keynote explores the ability of our Nano3A system to screen anti-mitochondrial antifungal, anticancer and anti-malarial drugs. Th is system consists of the Anti-mitochondrial Antifungal Assay (3A) linked to Nano Scanning Auger Microscopy (NanoSAM) and Nano Focused Ion Beam Time-of-Flight SIMS (NanoFIB-TOF) nanotechnologies. Here yeast sexual cells serve as indicators to screen drugs with anti-mitochondrial activity (3A system) while NanoSAM and NanoFIB-TOF are used to determine the drug’s metabolic fate as well as eff ects on sexual cell 3D ultrastructure and chemical composition as etching proceeds in nanometre slices through cell.

Professor Lodewyk Kock is regarded as an internationally acclaimed researcher. He published 150 articles in reputed journals and was involved in many interviews on national radio, television as well as Voice of America and Reuters TV. He was appointed as Director: Industrial Biotechnology UNESCO MIRCEN since 1998 and is at present Commissioner of the International Commission on Yeasts (ICY). He received the President’s Award for outstanding research from the National Research Foundation. Professor Lodewyk Kock (PhD) and Dr. Chantel Swart (PhD; Co-author) are from the Department of Microbial, Biochemical and Food Biotechnology from the University of the Free State in South Africa.